Neurogene(NGNE) - 2025 Q1 - Quarterly Results

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (date of earliest event reported): May 9, 2025 Neurogene Inc. (Exact name of registrant as specified in its charter) 535 W 24 Street, 5 Floor th th New York, NY 10011 (Address of principal executive offices, including zip code) Registrant's telephone number, including area code: (877) 237-5020 N/A (Former Name or Former Address, ...